Open an account

Cardio Diagnostics Holdings

CDIO · NASDAQ

$1.72+$0.08 (+4.88%)TodayMarket closed ·
Prev close $1.64

About CDIO

Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. The company is headquartered in Chicago, Illinois and currently employs 15 full-time employees. The company went IPO on 2021-11-23. The firm develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Employees
16
Headquarters
Chicago, Illinois
Listed
Nov 23, 2021
Sector
Health Care
Industry
Biotechnology
Website
cardiodiagnosticsinc.com

CDIO key statistics

Market cap
5.09M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
28.56K
Volume
53.14K
Open price
$1.66
High today
$1.78
Low today
$1.64
52 Week high
$6.08
52 Week low
$0.97

Cardio Diagnostics Holdings (CDIO) at a glance

Cardio Diagnostics Holdings (CDIO) last traded at $1.72, with a market cap of 5.09M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.64 and $1.78. The current price is 4.9% above the day's low and 3.4% below its high.

Volume so far is 53.14K shares, above the average of 28.56K shares a day.

Over the past year Cardio Diagnostics Holdings has ranged from $0.97 to $6.08, and now sits 15% of the way up that range.

Cardio Diagnostics Holdings met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q1 FY25 it reported -$0.97 per share against an estimate of -$1.84.

CDIO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 60.2% on average.

  1. Q2 FY23: reported -$11.70 per share against an estimate of -$5.66
  2. Q3 FY23: reported -$4.80 per share against an estimate of -$8.41
  3. Q4 FY23: reported $0.00 per share against an estimate of -$4.13
  4. Q1 FY24: reported -$6.00 per share against an estimate of -$2.75
  5. Q2 FY24: reported -$1.80 per share against an estimate of -$3.37
  6. Q3 FY24: reported -$1.80 per share against an estimate of -$3.06
  7. Q4 FY24: reported -$0.30 per share against an estimate of -$1.84
  8. Q1 FY25: reported -$0.97 per share against an estimate of -$1.84

CDIO news

  • Press releaseBusiness Wire

    Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges

  • Press releaseBusiness Wire

    Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City

  • Press releaseBusiness Wire

    Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026

  • Press releaseBusiness Wire

    Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network

  • Press releaseBusiness Wire

    Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June

  • Press releaseGlobe Newswire

    IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc.

  • Press releaseGlobe Newswire

    IBN Initiates Coverage of Cardio Diagnostics Holdings Inc.

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

Similar companies

Companies in the same industry as Cardio Diagnostics Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.